Emergent BioSolutions (EBS) PT Raised to $71 at Chardan Capital Markets

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. AMZN
10. LEN

Go back to Emergent BioSolutions (EBS) PT Raised to $71 at Chardan Capital Markets

Emergent BioSolutions Reports Fourth Quarter and Full Year 2018 Financial Results

February 21, 2019 4:06 PM EST

GAITHERSBURG, Md., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) reported financial results for the quarter and year ended December 31, 2018.

FINANCIAL HIGHLIGHTS

(in millions)Q4 2018(unaudited)Q4 2017(unaudited)Total Revenues$270.7$193.8Pretax... More